Can oxycodone (opioid analgesic) cause hallucinations and nightmares?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oxycodone Can Cause Hallucinations and Nightmares

Yes, oxycodone can cause hallucinations and nightmares as recognized side effects, particularly as manifestations of opioid-induced neurotoxicity. 1, 2

Neuropsychiatric Side Effects of Oxycodone

  • Hallucinations and nightmares are known adverse effects of oxycodone, though they occur less frequently than common side effects like constipation, nausea, and drowsiness 1, 3
  • These neuropsychiatric symptoms are part of a spectrum of opioid-induced neurotoxicity that can also include delirium, cognitive impairment, and myoclonus 2
  • Hallucinations with oxycodone may occur less frequently compared to morphine, as noted in comparative studies 3, 4
  • Opioid-induced hallucinations can be misdiagnosed as primary psychiatric disorders if the temporal relationship with opioid use is not recognized 5

Risk Factors and Mechanisms

  • Neuropsychiatric side effects are more likely to occur during:

    • Treatment initiation or dose titration phases 1
    • Rapid dose escalation 2
    • Accumulation of metabolites in patients with renal or hepatic impairment 2, 1
    • High-dose opioid therapy 1
  • Oxycodone is metabolized in the liver to active metabolites including oxymorphone, which may contribute to its side effect profile 3

Management of Oxycodone-Induced Hallucinations

If hallucinations or nightmares occur with oxycodone, the following approaches should be considered:

  1. Dose reduction if pain is well-controlled 1
  2. Opioid rotation to a different opioid (switching to another pure agonist such as fentanyl) if hallucinations persist despite dose adjustment 1, 2
  3. Rule out other causes of hallucinations or nightmares, including:
    • Metabolic disorders 1
    • Drug interactions with other medications 1
    • Underlying psychiatric conditions 5

Monitoring and Prevention

  • Patients should be informed about the possibility of hallucinations and nightmares when starting oxycodone therapy 1
  • Symptoms typically appear within the first few days or weeks of treatment and often resolve with continued use 1
  • For patients with a history of opioid-induced neurotoxicity, closer monitoring is recommended as they are at higher risk for recurrence 2
  • Patients with renal insufficiency require special caution due to potential accumulation of metabolites 2, 1

Clinical Implications

  • In a study of cancer patients, switching from morphine to oxycodone resulted in statistically significant improvements in mental state for those experiencing morphine-induced delirium 6
  • However, in patients specifically susceptible to opioid-induced neurotoxicity, any opioid including oxycodone can potentially cause hallucinations 2
  • The incidence of hallucinations and somnolence with opioids used for cancer pain was found to be approximately 5% and 23% respectively in a Cochrane review 7

In clinical practice, recognizing the potential for oxycodone to cause hallucinations and nightmares is important for proper management. If these symptoms occur, adjusting the dose or rotating to a different opioid can often resolve the issue while maintaining adequate pain control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid-Induced Opsoclonus-Myoclonus Syndrome Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Research

A review of oxycodone's clinical pharmacokinetics and pharmacodynamics.

Journal of pain and symptom management, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.